Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch...

Area of Science:

• Molecular Biology
• Cancer Genomics

Background:

• Recurrent spliceosome mutations are found in human cancers, but their functional roles are unclear.
• SF3B1, frequently mutated in cancer, plays a key role in RNA splicing by recognizing the branch point sequence (BPS) for 3' splice site (ss) selection.

Purpose of the Study:

• To investigate the functional consequences of SF3B1 mutations in cancer.
• To identify the specific splicing defects caused by SF3B1 mutations and their impact on gene expression.

Main Methods:

• Analysis of splicing aberrations in cancer cells with SF3B1 mutations.
• Characterization of the mechanism by which mutant SF3B1 affects 3' ss selection.
• Assessment of the impact of aberrant splicing on mRNA stability and protein expression.

Main Results:

• SF3B1 mutations induce common and tumor-specific splicing aberrations, with aberrant 3' ss selection being the most frequent defect.
• Mutant SF3B1 uses a distinct BPS and requires the canonical 3' ss for aberrant splicing.
• Approximately 50% of aberrantly spliced mRNAs undergo nonsense-mediated decay, leading to reduced gene and protein expression.

Conclusions:

• SF3B1 mutations have significant functional consequences in cancer by disrupting RNA splicing.
• Aberrant 3' ss selection and subsequent nonsense-mediated decay are key mechanisms linking SF3B1 mutations to altered gene expression in cancer.
• These findings highlight the importance of spliceosome mutations in cancer pathogenesis and suggest potential therapeutic strategies targeting these defects.